Gene-drug interactions (data source: DGIdb)
Gene Name Entrez ID Drug Name Chembl ID Interaction Types Sources publications

Variant-drug associations (data source: PharmGKB)
Gene Name Variant Alleles Chemical Phenotype Category Significance Notes Sentence Publications Annotation ID
HMGB2 rs6832850 A Platinum compounds efficacy no No significant association was found between this SNP and response to platinum-based chemotherapy, in any genetic model (i.e. additive (p=0.86), genotypic (p=0.85), dominant (p=0.62) or recessive (p=0.66)). Responders defined as complete or partial remission, non-responders defined as progressive or stable disease. 236 patients had non-small cell lung cancer and 102 had small cell lung cancer. Allele A is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T. 24684392 1444698898
HMGB2 rs7686909 C Platinum compounds efficacy no No significant association was found between this SNP and response to platinum-based chemotherapy, in any genetic model (i.e. additive (p=0.87) or dominant (p=0.67)). Responders defined as complete or partial remission, non-responders defined as progressive or stable disease. 236 patients had non-small cell lung cancer and 102 had small cell lung cancer. Allele C is not associated with response to Platinum compounds in people with Lung Neoplasms as compared to allele T. 24684392 1444698904